α-Synuclein Seeding Amplification Assay: A Breakthrough in Diagnosing Parkinson Disease?

John P. Seibyl

doi:10.2967/jnumed.123.266191

Research ArticleHot Topics

α-Synuclein Seeding Amplification Assay: A Breakthrough in Diagnosing Parkinson Disease?

John P. Seibyl

Journal of Nuclear Medicine February 2024, 65 (2) 174-175; DOI: https://doi.org/10.2967/jnumed.123.266191

John P. Seibyl

Institute for Neurodegenerative Disorders and Yale University School of Medicine, New Haven, Connecticut

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Download figure
Open in new tab
Download powerpoint
FIGURE 1.
Schematic of neuronal NSD-ISS, biologically rooted, evidence-based hybrid staging schema for clinical research on neuronal synucleinopathies, PD, and Lewy body dementia. (Reprinted with permission of (11).)

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 65, Issue 2

February 1, 2024

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following α-Synuclein Seeding Amplification Assay: A Breakthrough in Diagnosing Parkinson Disease?

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.